The anti-diabetic drug phenformin may prompt stronger cancer-fighting activities than its sister compound metformin, a finding that could have major implications for current and future clinical […]
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) concludes that the current evidence is insufficient to ascertain the balance of benefits and harms of screening asymptomatic adults […]
A new study, led by the University of California, Irvine (UCI), reveals how chronic inflammation promotes muscle fibrosis, which could inform the development of new therapies […]